Improving Chronic Kidney Disease Care for All Laboratorians explore how use of the updated estimated glomerular filtration rate equations differs for transgender patients and how to interpret laboratory test results in transgender and nonbinary populations. Learn More
New Guidance on Point-of-Care testing for Reproductive Health In September, AACC issued new guidance for point-of-care testing for fertility and reproductive health that incorporates advancements in knowledge about the accuracy of these kinds of tests and how the technology is rapidly surging. Learn More
Where Does the IVD Market Go After the Coronavirus Testing Surge? In 2022, testing for SARS-CoV-2 is expected to add almost $33 billion to the in vitro diagnostic (IVD) market. Thereafter, SARS-CoV-2 testing is projected to decline about 6% per year to about $23 billion in 2027. Learn More
Mitigating Test Interference From Antioxidant Vitamins Vrajesh “Raj” Pandya, PhD, DABCC, explores how clinical laboratories can mitigate test interference from megadose antioxidant vitamins. Learn More
How to Avoid Analytical Interferences in Trace Element Analysis Trace element testing helps clinical laboratories avoid analytical interferences from toxic metals that can sometimes be found in the human body. Learn More
White House Issues Framework for Artificial Intelligence Bill of Rights The White House Office of Science and Technology Policy has identified five principles to guide the design, use, and deployment of automated systems to protect the public in the age of artificial intelligence. Learn More
How to Approach Antimicrobial Stewardship After COVID-19 Elizabeth Palavecino, MD, discusses changes she's seen in antimicrobial stewardship programs throughout her career and during the COVID-19 pandemic. Learn More
How to Select Clinically Relevant Targets for Infectious Disease Panels Stella Antonara, PhD, D(ABMM), discusses how clinical laboratories should approach creating and evaluating infectious disease panels and how the changing role of point-of-care testing could affect infectious disease testing in the future. Learn More
IMMY Receives Federal Grant to Develop Talaromycosis Rapid Test IMMY has been awarded a 3-year, $1.5 million National Institute of Allergy and Infectious Disease contract for developing and validating a talaromyces point-of-care test. Learn More
Emergency Use Authorization Granted to Quest Monkeypox Test Quest Diagnostics has received Food and Drug Administration emergency use authorization for a lab-developed molecular diagnostic test to aid in the diagnosis of monkeypox virus infection. Learn More
Some People More Prone to COVID-19 Vaccine Side Effects Among individuals who have received COVID-19 vaccines, younger people, females, and those who got the second dose of the Moderna COVID-19 vaccine report more side effects from COVID-19 vaccines that may have led to moderate and severe limitations. Learn More